















































|
DIABETES IN
PREGNANCY - COMPLICATIONS - CONGENITAL ABNORMALITY
|
Diabetes Care. 2006 Aug;29(8):1744-9.
Prepregnancy care and pregnancy outcomes in women with type 1 diabetes.
Temple RC, Aldridge VJ, Murphy HR.
Elsie Bertram Diabetes Centre, Norfolk and Norwich University Hospital, UK.
rosemary. Temple@nnuh.nhs.uk
Objectives:
The objective of this study was to examine the relationship
between prepregnancy care, glycemic control, maternal hypoglycemia, and
pregnancy outcomes in women with type 1 diabetes. RESEARCH DESIGN AND
Methods:
This was a prospective observational cohort study of women with
type 1 diabetes who delivered from 1991 to 2002. Outcome measures were
attendance at a clinic for prepregnancy care, maternal HbA(1c) (A1C)
throughout pregnancy, maternal severe hypoglycemic episodes, macrosomia,
preeclampsia, premature delivery (delivery before 37 weeks), very premature
delivery (delivery before 34 weeks), spontaneous abortion, and adverse
pregnancy outcome (defined as major malformation, stillbirth, and neonatal
death).
Results:
There were 290 pregnancies, in which 110 (38%) women had
prepregnancy care. The prepregnancy care group contained more primiparous
women (54.7 vs. 40.6%; P = 0.021) and fewer smokers (9.4 vs. 28.7%; P <
0.0001). They registered earlier (6.6 vs. 8.3 weeks, P < 0.0001) and had a
lower A1C at the initial visit (6.5% vs. 7.6%; P < 0.0001). Adverse
pregnancy outcomes and very premature deliveries were significantly lower in
women who received prepregnancy care (2.9 vs. 10.2%; P = 0.03 and 5.0 vs.
14.2%; P = 0.02, respectively). In contrast, between groups, there was no
difference in A1C after 24 weeks or in the rates of macrosomia, preeclampsia,
or maternal severe hypoglycemic episodes.
Conclusions:
Prepregnancy care was
associated with improved glycemic control in early pregnancy and significant
reductions in adverse pregnancy outcome (malformation, stillbirth, and
neonatal death) and very premature delivery. However, prepregnancy care
failed to have an impact on glycemic control in later pregnancy or to reduce
the risk of macrosomia and preeclampsia.
|
|